Outcome | Group A (HMG300IU + MPA) (n = 109) | Group B (HMG300IU + MPA + CC) (n = 88) | Group A vs Group B | |||
---|---|---|---|---|---|---|
P | Crude OR (95% CI) | Adjusted P | Adjusted OR (95% CI) | |||
Number of transferred embryos | 1.95 ± 0.45 | 1.86 ± 0.48 | 0.223 | – | – | – |
Endometrial thickness (mm) | 9.79 ± 1.79 | 9.57 ± 1.82 | 0.395 | – | – | – |
Clinical pregnancy rate (%) | 37.61 (41/109) | 32.95 (29/88) | 0.497 | 1.230 (0.680–2.211) | 0.441 | 1.286 (0.671–2.470) |
Live birth rate (%) | 41.46 (17/41) | 34.48 (10/29) | 0.555 | 1.353 (0.496–3.611) | 0.551 | 1.390 (0.478–3.990) |
Miscarriage rate (%) | 29.27 (12/41) | 20.69 (6/29) | 0.420 | 0.632 (0.210–1.942) | 0.728 | 1.091 (0.261–4.660) |
Ongoing pregnancy rate (%) | 17.07 (7/41) | 17.24 (5/29) | 0.985 | 0.988 (0.280–3.487) | 0.534 | 1.672 (0.331–8.455) |
Biochemical pregnancy rate (%) | 9.17 (10/109) | 7.95 (7/88) | 0.762 | 0.857 (0.311–2.346) | 0.905 | 0.932 (0.307–2.844) |
Gestational age (wk) | 37.93 ± 1.50 | 37.87 ± 2.29 | 0.605 | – | – | – |
< 37 weeks | 23.53 (4/17) | 20 (2/10) | 0.831 | 0.809 (0.120–5.496) | 0.179 | 0.041 (0.000–4.348) |
≥ 37 weeks | 76.47 (13/17) | 80 (8/10) | – | Ref | – | Ref |
Birth weights (g) | 3014.44 ± 357.26 | 2895.83 ± 393.39 | 0.545 | – | – | – |
Less than 2500 | 5.88 (1/17) | 10 (1/10) | 0.696 | 1.782 (0.102–31.976) | 0.999 | – |
2500–4000 | 94.12 (16/17) | 90 (9/10) | – | Ref | – | Ref |